Related Experiment Video
Updated: Apr 20, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
6.0K
Novel prognostic tissue markers in congestive heart failure
1Center for Systems Biology, Massachusetts General Hospital and Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Summary
Novel tissue markers in heart failure biopsies can predict patient outcomes, even when biopsies are otherwise negative. These biomarkers offer superior prognostic information compared to traditional clinical and serum markers.
Area of Science:
- Cardiology
- Biomarker Discovery
- Prognostic Medicine
Background:
- Heart failure (HF) presents significant morbidity, mortality, and economic challenges.
- Accurate prognostic tools are crucial for optimizing HF patient management and resource allocation.
- Endomyocardial biopsies, while diagnostic, often yield non-specific findings.
Purpose of the Study:
- To identify novel tissue markers in endomyocardial biopsies for improved heart failure prognosis.
- To evaluate the prognostic utility of these markers, including ubiquitin, Gremlin-1, cyclophilin A, and heterogeneous nuclear ribonucleoprotein C.
- To determine if these markers offer prognostic value independently of or superior to existing clinical and serum indices.
Main Methods:
- Analysis of endomyocardial biopsy samples from heart failure patients.
- Identification and quantification of specific novel tissue markers.
- Correlation of marker levels with patient outcomes and comparison with clinical/serum indices.
Main Results:
- Novel tissue markers (ubiquitin, Gremlin-1, cyclophilin A, hnRNP C) identified in endomyocardial biopsies.
- These markers demonstrated prognostic capability in heart failure patients.
- In some instances, tissue markers provided superior or independent prognostic information compared to clinical and serum markers.
Conclusions:
- Novel tissue markers in endomyocardial biopsies hold significant potential for predicting heart failure prognosis.
- These biomarkers may offer valuable prognostic insights, particularly in cases with non-diagnostic biopsies.
- Further research into these markers can enhance clinical decision-making and patient care strategies in heart failure.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
789
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
789
01:29Heart Failure II: Pathophysiology
1.6K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.6K
01:17Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
01:30Acute Coronary Syndrome III: Diagnostic Studies
484
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
01:30Heart Failure IV: Classification and Diagnostic Evaluation
649
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
649